Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
November 20, 2008

Stem Cell Sciences to Provide Stem Cell Technologies to Pfizer’s New Regenerative Medicine Unit

  • Stem Cell Sciences (SCS) signed a Master Service Agreement of up to five years with Pfizer Limited, the U.K. operating unit of Pfizer.

    Under the terms of the agreement, SCS will provide research services, cell lines, media, and reagents to support R&D efforts at Pfizer’s new Regenerative Medicine Unit, which was launched last week.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.